Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to investigate differences of the bowel wall thickness visible in conventional ultrasound and bowel perfusion using quantitative Contrast-Enhanced Ultrasound in patients with Crohn´s disease in comparison with healthy controls and patients with food allergy.
After being informed about the study and potential risks, all participants giving written consent will undergo conventional transabdominal ultrasound and Contrast-Enhanced Ultrasound of the bowel wall with measurement of the bowel wall thickness. In addition a continuous video sequence during Contrast-Enhanced Ultrasound is recorded and perfusion kinetics from the video clips are analyzed using a specific quantification software.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Active Crohn´s disease | Ultrasound in patients with proven active Crohn´s disease scheduled for therapy with anti tumor necrosis factor alpha antibodies | ||
| Patients with Food allergy | Patients with proven food allergy |
| |
| Healthy controls | Healthy, food-tolerant volunteers without any abdominal complaint |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Mild diet | Other |
| ||
| Provocative diet |
| Measure | Description | Time Frame |
|---|---|---|
| Bowel wall thickness | Thickness of the bowel wall measured in high-frequency ultrasound from the center of the lumen to the serosa | T0: Baseline after mild diet. T1: After provocative diet (up to 30 days from T0) |
| Peak Enhancement | Maximum point of the DCE-US curve assessed in Contrast-Enhanced Ultrasound | T0: Baseline after mild diet. T1: After provocative diet (up to 30 days from T0) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Tertiary-care university hospital, patients diagnosed and treated in the outpatient department for inflammatory and allergic bowel diseases
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Dane Wildner, M.D. | Department of Medicine 1, Divison of ultrasound medicine, University Hospital Erlangen | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003424 | Crohn Disease |
| D005512 | Food Hypersensitivity |
| ID | Term |
|---|---|
| D015212 | Inflammatory Bowel Diseases |
| D005759 | Gastroenteritis |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Other |
|
| D007410 | Intestinal Diseases |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |